Skip to main content
Frontiers in Chemistry logoLink to Frontiers in Chemistry
. 2019 Nov 26;7:804. doi: 10.3389/fchem.2019.00804

Corrigendum: Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents

H A Arjun 1, Ramakrishnan Elancheran 1, N Manikandan 2, K Lakshmithendral 1, Muthiah Ramanathan 2, Atanu Bhattacharjee 3, N K Lokanath 4, Senthamaraikannan Kabilan 1,*
PMCID: PMC6901999  PMID: 31840023

In the original article, there was a mistake in the Figure 4 as published. Figure 4 was not appropriated for the tested compound 6g. The corrected Figure 4 appears below.

Figure 4.

Figure 4

The morphological changes in 6g and Zebularine treated in prostate cancer cell line. The treated and untreated cells were stained with Acridine orange and Ethidium bromide and observed under an inverted fluorescent microscope. Live cells appear green, late apoptotic cells are appearing orange in color, and necrotic cells are colored red.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


Articles from Frontiers in Chemistry are provided here courtesy of Frontiers Media SA

RESOURCES